ITMO University has created an AI-based algorithm, which significantly accelerates the search for promising compounds for autoimmune drugs development. The technology reduces the multi-year process of ...

The Ministry of Health of the Russian Federation has started searching for a contractor for the construction of a full-cycle Research and Production Complex for the creation of somatic cell based ...

Rospotrebnadzor will conduct preclinical trials of the avian influenza vaccine. The head of the department, Anna Popova, said in an interview with TASS that six prototypes of vaccines are currently ...

NC Logistic has become the first logistics operator in the Russian pharmaceutical market to receive a GMP certificate. For this purpose, the company has developed its own pharmaceutical quality system ...

The Russian Ministry of Health is engaged in intense work to create its own production of immunoglobulins, including antiresus for the prevention of rhesus conflict in pregnant women. According to the ...

The Sechenov First Moscow State Medical University and the Association of Pharmaceutical Manufacturers of the EAEU (APMEAEU) have signed a cooperation agreement at the 32nd Russian Pharmaceutical ...

The R-Pharm Group has launched a platform for the creation of innovative therapeutic antibodies at the Laboratory for the Early Development of Biological Drugs in Pushchino, Moscow region. According ...

Researchers at Perm National Research Polytechnic University (PNRPU) have developed a new class of organic compounds with a pronounced analgesic effect and minimal toxicity. The PNRPU press service ...

A quantum algorithm of generative artificial intelligence (AI) has been developed and successfully tested in Russia for use in chemistry and drug development. This was announced by Aleksey Fedorov, ...

Russian Prime Minister Mikhail Mishustin signed a decree on the establishment of the Innovation Research and Technology Center (IRTC) PhysTech Valley in Dolgoprudny (Moscow region). One of the ...

The Russian company Pharmasyntez intends to bring 3 innovative domestic drugs to the market in 2025-2026, said Vikram Punia, the owner of the group, at the 32nd N.A. Semashko Russian Pharmaceutical ...

The Russian holding company Natsimbio (part of Rostec Group) will continue to develop a combined vaccine against influenza and COVID-19 with another partner and using another platform. Earlier, the ...